Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena I Ivleva

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Schizophrenia Bulletin|May 28, 2015
Frequency-Specific Neural Signatures of Spontaneous Low-Frequency Resting State Fluctuations in Psychosis: Evidence From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) ConsortiumShashwath A Meda, Zheng Wang, Elena I Ivleva, et al.
Schizophrenia Research|July 18, 2020
Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorderMilena Y Gotra, Scot K Hill, Elliot S Gershon, et al.
Schizophrenia Research|July 7, 2020
No connectivity alterations for striatum, default mode, or salience network in association with self-reported antipsychotic medication dose in a large chronic patient groupEmma N Herms, Jeffrey R Bishop, Victoria T Okuneye, et al.
Schizophrenia Research|September 1, 2023
Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1Brett A Clementz, Ishanu Chattopadhyay, Rebekah L Trotti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 8, 2019
A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampusE Sherwood Brown, Nasreen Sayed, Changho Choi, et al.
Schizophrenia Bulletin|May 31, 2025
Brain Age Disparities in Psychosis Across DSM Diagnoses and B-SNIP BiotypesLiisi Promet, Shashwath A Meda, Ney Alliey-Rodriguez, et al.
Biomarkers in Neuropsychiatry|May 12, 2025
Cognitive performance and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT) - 2Brett A Clementz, Ishanu Chattopadhyay, S Kristian Hill, et al.
Schizophrenia Research|October 24, 2017
Genetic analysis of deep phenotyping projects in common disordersElliot S Gershon, Godfrey Pearlson, Matcheri S Keshavan, et al.
Advances in Neurobiology|November 19, 2024
Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis BiotypesBrett A Clementz, Michal Assaf, John A Sweeney, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 8, 2019
Brain gray matter network organization in psychotic disordersWenjing Zhang, Du Lei, Sarah K Keedy, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Schizophrenia Bulletin|May 28, 2015
Frequency-Specific Neural Signatures of Spontaneous Low-Frequency Resting State Fluctuations in Psychosis: Evidence From Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) ConsortiumShashwath A Meda, Zheng Wang, Elena I Ivleva, et al.
Schizophrenia Research|July 18, 2020
Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorderMilena Y Gotra, Scot K Hill, Elliot S Gershon, et al.
Schizophrenia Research|July 7, 2020
No connectivity alterations for striatum, default mode, or salience network in association with self-reported antipsychotic medication dose in a large chronic patient groupEmma N Herms, Jeffrey R Bishop, Victoria T Okuneye, et al.
Schizophrenia Research|September 1, 2023
Clinical characterization and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT)-1Brett A Clementz, Ishanu Chattopadhyay, Rebekah L Trotti, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 8, 2019
A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampusE Sherwood Brown, Nasreen Sayed, Changho Choi, et al.
Schizophrenia Bulletin|May 31, 2025
Brain Age Disparities in Psychosis Across DSM Diagnoses and B-SNIP BiotypesLiisi Promet, Shashwath A Meda, Ney Alliey-Rodriguez, et al.
Biomarkers in Neuropsychiatry|May 12, 2025
Cognitive performance and differentiation of B-SNIP psychosis Biotypes: Algorithmic Diagnostics for Efficient Prescription of Treatments (ADEPT) - 2Brett A Clementz, Ishanu Chattopadhyay, S Kristian Hill, et al.
Schizophrenia Research|October 24, 2017
Genetic analysis of deep phenotyping projects in common disordersElliot S Gershon, Godfrey Pearlson, Matcheri S Keshavan, et al.
Advances in Neurobiology|November 19, 2024
Categorical and Dimensional Approaches for Psychiatric Classification and Treatment Targeting: Considerations from Psychosis BiotypesBrett A Clementz, Michal Assaf, John A Sweeney, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 8, 2019
Brain gray matter network organization in psychotic disordersWenjing Zhang, Du Lei, Sarah K Keedy, et al.
Pageof 8